Trial Profile
Rosuvastatin combined with ezetimibe in patients at high risk for cardiovascular safety and efficacy evaluation of combined hepatitis B virus carriers
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Aug 2014
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Rosuvastatin (Primary)
- Indications Cardiovascular disorders
- Focus Adverse reactions; Therapeutic Use
- 08 Aug 2014 New trial record